Table 2.

Characteristics of subjects in the Mount Sinai cohort.

Diagnosis	Sex	Age, years	PMI hours	pH	Psychotropic Medication/Dose (mg/day)	Cause of death
SZ1	F	80	6.9	6.8	Thiothixene – 5; Chlorpromazine – 100;	Acute pancreatitis, renal failure.
SZ	M	58	6.7	6.2	Haloperidol – 2 or 4	Cardio pulmonary arrest.
SZ	M	84	5.25	7.0	Haloperidol - 2	Cardio pulmonary arrest.
SZ	M	58	22.3	6.9	Haloperidol – from 0.5 to 20	Cardiac Arrest
SZ	M	63	6.2	5.9	Haloperidol - 8	Gastrointestinal hemorrhage
SZ	F	83	20.4	7.1	Thioridazine; Thiothixene	Cancer of pancreas
SZ	F	79	9.9	6.8	Thiothixene - 4	Atherosclerotic Heart Disease
SZ	F	70	29.9	6.5	Risperidone – 2–6	Cardiac arrest
SZ	M	69	23.5	6.7	Loxapine – 10–15; Perphenazine – 4–24	Acute renal failure
SZ	F	77	9.7	6.0	Risperidone - 5	Myocardial infarction
N=10	5F+5M	72.1±3.12	14.1±2.83	6.5±0.094
Control	F	82	5.7	6.1	none	Myocardial infarction
Control	F	80	4.75	6.2	none	Sepsis
Control	F	85	4.3	6.3	none	Myocardial infarction
Control	F	102	7.1	6.5	none	Myocardial infarction, Ovarian tumors
Control	M	101	4.7	6.8	none	Congestive Heart Failure
Control	F	78	10	6.2	none	Myocardial infarction
Control	M	95	4.1	6.5	none	Renal failure
Control	M	65	3.8	6.8	none	Renal Failure
Control	F	83	6.2	6.8	none	Atherosclerotic Heart Disease
Control	M	66	7.6	6.6	none	Congestive Heart Failure
N=10	6F+4M	83.7±4.1	5.8±0.6	6.6±0.13

¹– SZ – schizophrenia;

²– Age is significantly lower in the SZ group (t(18)=2.26, p=0.036).

³– PMI is significantly longer in the SZ group (t(18)=2.84, p=0.011).

⁴– There are no significant differences in brain pH between the groups (t(18)=0.693, p=0.496).